PIK3CA(H1047R)-induced paradoxical ERK activation results in resistance to BRAF(V600E) specific inhibitors in BRAF(V600E) PIK3CA(H1047R) double mutant thyroid tumors

Thyroid carcinomas are the most prevalent endocrine cancers. The BRAF(V600E) mutation is found in 40% of the papillary type and 25% of the anaplastic type. BRAF(V600E) inhibitors have shown great success in melanoma but, they have been, to date, less successful in thyroid cancer. About 50% of anapla...

Descripción completa

Detalles Bibliográficos
Autores principales: Roelli, Matthias A., Ruffieux-Daidié, Dorothée, Stooss, Amandine, ElMokh, Oussama, Phillips, Wayne A., Dettmer, Matthias S., Charles, Roch-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732722/
https://www.ncbi.nlm.nih.gov/pubmed/29262556
http://dx.doi.org/10.18632/oncotarget.21732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732722/
https://www.ncbi.nlm.nih.gov/pubmed/29262556
http://dx.doi.org/10.18632/oncotarget.21732

Ejemplares similares